Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
July 31, 2017
BioLife Solutions Executes Supply Agreement with Celyad for CryoStor® Use in Natural Killer Receptor based T-Cell (NKR-T) Platform Targeting Solid Tumors and Blood Cancers
BOTHELL, Wash., July 31, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage ...
July 31, 2017
BioDelivery Sciences Publishes Shareholder Letter with Mid-Year Corporate Update
RALEIGH, N.C., July 31, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, announced ...
July 31, 2017
Mateon Therapeutics Announces Positive Initial Data from Fifth Cohort of Phase 1b Study of OXi4503 in Relapsed/Refractory AML
SOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment ...
July 31, 2017
iCAD to Report Second Quarter 2017 Financial Results on Tuesday, August 8
NASHUA, N.H., July 31, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the ...
July 31, 2017
Ohr Pharmaceutical to Announce Fiscal Third Quarter 2017 Results on August 8
NEW YORK, July 31, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that ...
July 31, 2017
Altimmune to Announce Second Quarter 2017 Financial Results on August 10
GAITHERSBURG, Md., July 31, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced that it will report financial results for the ...
July 31, 2017
Arena Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
SAN DIEGO, July 31, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that the underwriters of its previously announced underwritten public offering of 6,250,000 shares of ...
July 31, 2017
American Journal of Psychiatry Publishes Minerva Neurosciences' MIN-101 Phase 2b Trial Results for Treatment of Negative Symptoms in Schizophrenia
WALTHAM, Mass., July 31, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
July 31, 2017
Transgene: First Patient Dosed in a Phase 1/2 Trial of Pexa-Vec + Opdivo® for the First-Line Treatment of Advanced Liver Cancer
Transgene (TNG.PA), a company that designs and develops viral-based immunotherapies, today announces that the first patient has been treated in a Phase 1/2 clinical trial evaluating ...
July 31, 2017
Onxeo Divests Two Non-Core Products in Oral Pathologies to Vectans Pharma
Onxeo S.A. (ONXEO.PA) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or the “Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs ...
July 27, 2017
Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Public Offering
IRVING, Texas, July 26, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc.(Nasdaq:RETA) ("Reata" or the "Company"), a clinical-stage biopharmaceutical company, today announced the pricing of an ...
July 27, 2017
Kamada to Host Second Quarter 2017 Financial Results Conference Call on August 1
REHOVOT, Israel, July 27, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that it ...
July 27, 2017
VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine
CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 07/27/17 -- VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced positive ...
July 27, 2017
Eiger Announces FDA Fast Track Designation Granted for Pegylated Interferon Lambda in Hepatitis Delta Virus Infection
PALO ALTO, Calif., July 27, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, today announced ...
July 27, 2017
Researchers to Present Clinical Data Supporting Use of Xoft System for Endometrial Cancer Treatment at American Association of Physicists in Medicine Annual Meeting & Exhibition
NASHUA, N.H. and DENVER, July 27, 2017 (GLOBE NEWSWIRE) -- (Booth #6010) -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and ...
July 27, 2017
Achaogen to Host Conference Call and Webcast of Second Quarter 2017 Financial Results on August 3, 2017
SOUTH SAN FRANCISCO, Calif., July 27, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company discovering and developing innovative antibacterials addressing multi-drug resistant ...
July 27, 2017
Minerva Neurosciences to Report Second Quarter 2017 Financial Results and Business Updates on August 3, 2017
WALTHAM, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
July 26, 2017
VALNEVA and Emergent BioSolutions Join Forces to Develop a Vaccine against the Zika Virus
Lyon (France), July 26, 2017 - Valneva SE (VLA), a fully integrated, commercial stage biotech company focused on developing innovative, life-saving vaccines, announces today that ...
July 26, 2017
Santen and TRACON Announce Initiation of a Phase 2a Study of DE-122 for the Treatment of Wet Age-Related Macular Degeneration
OSAKA, Japan and SAN DIEGO, July 25, 2017 (GLOBE NEWSWIRE) -- Santen Pharmaceutical Co. Ltd. (Santen) and TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) (TRACON) today announced that ...
July 26, 2017
Kiadis Pharma proposes former Actelion COO Otto Schwarz as new Supervisory Board member
Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative products to make bone marrow transplantations ...
Page 131 of 145